Objectives. To estimate the effect of California’s prescription drug monitoring program’s (PDMP) registration mandate on use of the PDMP.
Methods. We evaluated the effect of California’s mandatory PDMP registration law by fitting time series models on the percentage of clinicians registered for California’s PDMP and the percentage of clinicians who were active PDMP users (users who created ≥ 1 patient prescription reports in a given month) from 2010 through 2017. We also compared PDMP use among early PDMP adopters (clinicians who registered > 8 months before the mandatory registration deadline) versus late adopters (clinicians who registered ≤ 8 months before the deadline).
Results. Mandatory registration was associated with increases in active PDMP users: 53.5% increase for prescribers and 17.9% for pharmacists. Early adopters were 4 times more likely to be active PDMP users than were late adopters.
Conclusions. Mandatory registration was associated with increases in PDMP registration and use, but most new registrants did not become active users.
Public Health Implications. Mandatory PDMP registration increases PDMP use but does not result in widespread PDMP usage by all clinicians prescribing controlled substances.
- At the time of the study, Aaron B. Shev, Garen J. Wintemute, Magdalena Cerdá, and Andrew Crawford were with the Violence Prevention Research Program, Department of Emergency Medicine; Susan L. Stewart is with the Department of Public Health Sciences, Division of Biostatistics; and Stephen G. Henry is with the Department of Internal Medicine, Division of General Medicine, Geriatrics, & Bioethics, School of Medicine, University of California, Davis.
